REGENXBIO Inc.

RGNX · Healthcare · REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects…

REGENXBIO Inc. (RGNX), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 3 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 27 and filed Aug 27. The most active filer was Steve Pakola with 2 filings.

Add to watchlist

Filings, ttm

1 buy · 3 sells

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$2.1M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 27

Filed Aug 27

ADViAverage daily dollar volume

$23.2M

market data

Share price · 12M

$9.20 (+1.5%)

Adjusted for splits and dividends.

Volume by month

Buys $949K Sells $1.4M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Steve Pakola Chief Medical Officer 2 filings GC

Gregory Austin Ciongoli Director 1 filing AK

Argeris N Karabelas Director 1 filing KM

Kenneth T. Mills Director 1 filing CS

Curran Simpson Chief Executive Officer 1 filing

Recent filings

Gregory Austin CiongoliPURCHASE Director $949K
102,603 sh across 2 lots
Exec Aug 26
Filed Aug 27 · 7:03 PM ET Steve PakolaSALE Chief Medical Officer $689K
56,333 sh across 2 lots
Exec Jun 29
Filed Jul 1 · 8:08 PM ET Steve PakolaSALE Chief Medical Officer $169K
15,309 sh × $11.02
Exec May 11
Filed May 13 · 5:30 PM ET Curran SimpsonSALE Chief Executive Officer $263K
20,811 sh × $12.62
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET Kenneth T. MillsSALE Director $163K
20,602 sh × $7.91
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET Argeris N KarabelasSALE Director $101K
10,000 sh × $10.11
Exec Oct 1 2024
Filed Oct 2 2024 · 5:30 PM ET